But the plasma CXCL14 concentration was slightly higher in patients with lung cancer than in patients with BPNs (Benign pulmonary nodules), and the difference was not significant (cancer vs benign: 2053.46 vs 1611.06 pg/ml, P=0.209). This evidence concerns the gene CXCL14 and lung carcinoma.